Anxiety, depressive, and panic disorders are all common psychiatric comorbidities found in patients with migraine and headache disorders.
Your search for major depressive disorder returned 57 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
The FDA has approved Rexulti (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer disease.
A placebo-controlled study of smokers with MDD evaluated varenicline with vs without behavioral interventions for smoking cessation.
Investigators surveyed adolescents and young adults with self-reported ADHD to determine what proportion already engage in tolerance breaks from their medication, and how often.
In a systematic review and meta-analysis, researchers looked at cases of NMOSD attacks following vaccination and described the clinical features of these attacks.
Researchers sought to assess the overall impact of exercise interventions on HRQOL in patients with MS, the overall strength of evidence of exercise interventions on the physical and mental domains of HRQOL, and establish moderators of exercise intervention effects on HRQOL.
Investigators assessed the prevalence of exposure to medications with potential drug-drug interactions to ritonavir-containing COVID-19 therapy among US adults.
Patients with severe mental illness were evaluated for adherence, psychopathology, hospitalization, and adverse events before and after a first injectable long-acting injectable antipsychotic prescription.
Psilocybin treatment in a community setting appears safe and effective for patients with cancer and depression.
As early identification of symptoms and appropriate severity stratification are important for illness management, the aim of this study was to evaluate current data on markers for instability in anorexia nervosa.
Researchers sought to assess the link between baseline SVD severity and SVD progression on MRI markers and incident dementia, based on subtype, among individuals with sporadic SVD over a 14-year follow-up period.
Researchers studied the mental health outcomes of patients with rheumatic disease during the COVID-19 pandemic.
In a systematic literature review, researchers determined the global prevalence of head trauma among refugees and asylum seekers and described its common clinical characteristics in this population.
In this study, participants were followed for 2 years with the outcomes of interest being height, weight, cardiovascular health, and psychiatric outcomes.
This study looked at whether youth with ADHD, following 24-HMB recommendations, were less likely to have difficulty concentrating, remembering, or making decisions and making or keeping friends.
For this study in adults with OUD and insomnia receiving buprenorphine, investigators looked at whether women or men were more likely to be prescribed benzodiazepines.
Researchers identify 2 major risk factors for bipolar disorder in adulthood.
Researchers sought to identify factors associated with receiving mental health treatment following stroke and impacts on long-term outcomes.
Researchers sought to synthesize the current circadian features of cluster headache and migraine, with a focus on timing of attacks, chronotype, corticosteroids, melatonin, core circadian genes, and clock controlled genes.
A study was conducted to determine the effects of switching or augmenting antidepressant therapy in adults with treatment-resistant depression.
Investigators assessed whether use of montelukast in adults with asthma is associated with onset of neuropsychiatric adverse events.
In this study, participants underwent cardiorespiratory fitness (CRF) testing using the 6-minute walk test and perceived CRF was evaluated by asking participants what they thought their current aerobic fitness level was.
Researchers explored whether lowering cholesterol through statins in patients with OSA could improve endotheilial protection against complement.
Investigators searched publication databases through June 2021 for studies evaluating the efficacy of group-based PTSD interventions in the pediatric setting.
Patients with MDD were randomly assigned in a 1:1:1 ratio to receive 1.5 mg daily cariprazine, 3.0 mg daily cariprazine, or placebo for 6 weeks.
Authors say findings similar across people with schizophrenia, major depressive disorder, and bipolar disorder in three distinct geographic settings
Investigators searched publication databases for randomized controlled trials evaluating cognitive training and remediation interventions among patients with MDD.
Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.
However, expansion of telehealth yielded net increase in care for major depressive disorder, anxiety, and adjustment disorder
Researchers seek to evaluate whether trauma-focused therapy adjunctive to treatment as usual (TAU) leads to a greater reduction of depressive symptoms posttreatment vs TAU exclusively in patients with major depressive disorder with childhood trauma.
Latest News Your top articles for SaturdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses